Counterpoint Mutual Funds LLC Buys 898 Shares of McKesson Corporation $MCK

Counterpoint Mutual Funds LLC grew its stake in shares of McKesson Corporation (NYSE:MCK) by 34.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,505 shares of the company’s stock after buying an additional 898 shares during the period. Counterpoint Mutual Funds LLC’s holdings in McKesson were worth $2,708,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Solstein Capital LLC lifted its stake in McKesson by 171.4% in the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after purchasing an additional 24 shares in the last quarter. State of Wyoming bought a new position in shares of McKesson in the second quarter worth $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson in the third quarter worth $31,000. Abound Wealth Management raised its position in shares of McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after buying an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC bought a new stake in McKesson during the second quarter valued at $35,000. 85.07% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at $2,824,605. The trade was a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,143 shares of company stock worth $1,046,070 over the last ninety days. Company insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

MCK has been the topic of a number of research analyst reports. Robert W. Baird set a $968.00 target price on McKesson in a research note on Wednesday, January 14th. Evercore restated an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a research report on Thursday, November 6th. TD Cowen lifted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Zacks Research cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Finally, Morgan Stanley restated an “overweight” rating and set a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $943.50.

McKesson Stock Up 0.0%

NYSE MCK opened at $947.58 on Tuesday. The company has a 50-day simple moving average of $856.14 and a two-hundred day simple moving average of $798.99. McKesson Corporation has a 12-month low of $598.58 and a 12-month high of $971.93. The firm has a market cap of $116.07 billion, a price-to-earnings ratio of 27.25, a PEG ratio of 1.53 and a beta of 0.40.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.